Literature DB >> 12893008

Hydroxynonenal, toxic carbonyls, and Alzheimer disease.

Quan Liu1, Arun K Raina, Mark A Smith, Lawrence M Sayre, George Perry.   

Abstract

Cytoskeletal disruption is one of the distinguishing characteristics of the vulnerable neurons in Alzheimer disease (AD). It has been suggested that these cytoskeletal changes occur secondarily to covalent modifications of the protein components. Despite the abundance and probable importance of these changes, there has been very little data regarding the identity of the modified proteins or the precise chemistry of the modifications. Here we review a specific type of modification, namely carbonylation of proteins, which has been shown to be a common result of cellular oxidative stress. Hopefully, the following discussion will help elucidate the relationship between oxidative stress, protein modification and the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12893008     DOI: 10.1016/s0098-2997(03)00025-6

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  24 in total

Review 1.  Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.

Authors:  Kyung-Jin Kim; Phillip L Pearl; Kimmo Jensen; O Carter Snead; Patrizia Malaspina; Cornelis Jakobs; K Michael Gibson
Journal:  Antioxid Redox Signal       Date:  2011-04-10       Impact factor: 8.401

Review 2.  Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?

Authors:  Barry Halliwell; Matthew Whiteman
Journal:  Br J Pharmacol       Date:  2004-05       Impact factor: 8.739

3.  Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: Role of lipid peroxidation in Alzheimer's disease pathogenesis.

Authors:  Marzia Perluigi; Rukhsana Sultana; Giovanna Cenini; Fabio Di Domenico; Maurizio Memo; William M Pierce; Raffaella Coccia; D Allan Butterfield
Journal:  Proteomics Clin Appl       Date:  2009-06-01       Impact factor: 3.494

4.  Oxidative stress and 17-alpha- and 17-beta-estradiol modulate neurofilaments differently.

Authors:  Keith Chiasson; Vicky Lahaie-Collins; Julie Bournival; Benoit Delapierre; Sylvie Gélinas; Maria-Grazia Martinoli
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

5.  Formation of 4-hydroxynonenal from cardiolipin oxidation: Intramolecular peroxyl radical addition and decomposition.

Authors:  Wei Liu; Ned A Porter; Claus Schneider; Alan R Brash; Huiyong Yin
Journal:  Free Radic Biol Med       Date:  2010-11-01       Impact factor: 7.376

Review 6.  P2Y2 nucleotide receptor-mediated responses in brain cells.

Authors:  Troy S Peterson; Jean M Camden; Yanfang Wang; Cheikh I Seye; W G Wood; Grace Y Sun; Laurie Erb; Michael J Petris; Gary A Weisman
Journal:  Mol Neurobiol       Date:  2010-04-13       Impact factor: 5.590

7.  Can urinary excretion rate of 8-isoprostrane and malonaldehyde predict postoperative cognitive dysfunction in aging?

Authors:  Qinghao Cheng; Jiawan Wang; Anshi Wu; Rujin Zhang; Lei Li; Yun Yue
Journal:  Neurol Sci       Date:  2013-02-05       Impact factor: 3.307

Review 8.  Antioxidant therapy in Alzheimer's disease: theory and practice.

Authors:  Gjumrakch Aliev; Mark E Obrenovich; V Prakash Reddy; Justin C Shenk; Paula I Moreira; Akihiko Nunomura; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Mini Rev Med Chem       Date:  2008-11       Impact factor: 3.862

Review 9.  Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation.

Authors:  Claus Schneider; Ned A Porter; Alan R Brash
Journal:  J Biol Chem       Date:  2008-02-19       Impact factor: 5.157

10.  Brain mitochondrial dysfunction in aging, neurodegeneration, and Parkinson's disease.

Authors:  Ana Navarro; Alberto Boveris
Journal:  Front Aging Neurosci       Date:  2010-09-01       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.